MarketCapExport financials
GeoVax Labs (GOVXW)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
GeoVax Labs Balance Sheet 2025-2001 | GOVXW
Brief balance sheet overview of GeoVax Labs
The balance sheet is assessed across five available annual reports spanning 2020 to 2025.
Assets rose from $10.4 thousand to $6.3 million, a gain of +60,915.3%, while CAGR was about 260.7%. The balance sheet expanded rapidly.
Asset growth of +60,915.3% came with a +304,941.5% rise in liabilities. Financial leverage became more prominent.
The equity-to-assets ratio is 60.3%, compared with 92,062.2% five periods ago. The balance sheet has a substantial internal cushion.
The balance sheet holds more cash than interest-bearing debt; net debt is -$2.2 million, indicating minimal leverage.
Retained earnings are negative at -$150.8 million. This reduces the formal capital cushion, although large shareholder returns may have contributed.
Overall assessment
GeoVax Labs's balance sheet sends more positive than negative signals, but liabilities should not begin outpacing the capital base.
Annual Balance Sheet GeoVax Labs
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-2.24 M | - | - | - | - | -9.7 K | -271 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt |
580 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
263 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
1.94 M | 3.11 M | 3.52 M | 4.75 M | 5.44 M | 810 K | 2.02 M | 1.62 M | 811 K | 370 K | 127 K | 187 K | 312 K | 327 K | 942 K | 522 K | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.52 M | 3.11 M | - | 4.75 M | 7.44 M | 825 | 2.04 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-151 M | -129 M | -104 M | -78.4 M | -64.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
6.34 M | 8.16 M | 9.28 M | 31.3 M | 11.8 M | 10.4 K | 469 K | - | - | - | - | - | - | - | - | 2.36 M | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
3.09 M | 5.51 M | 6.45 M | 27.6 M | 11.4 M | 9.88 M | 283 K | 260 K | 313 K | 454 K | 1.06 M | 1.1 M | 2.51 M | 1.04 M | 1.17 M | 1.08 M | 3.52 M | 2.19 M | - | - | - | - | - | - | - |
Book Value |
3.83 M | 5.05 M | 9.28 M | 26.6 M | 4.36 M | 9.57 K | -1.57 M | - | - | - | - | - | - | - | - | 2.36 M | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
3.83 M | 5.05 M | 5.76 M | 26.6 M | 4.36 M | 9.57 M | -1.57 M | -1.02 M | -321 K | 240 K | 1.2 M | 1.15 M | 2.53 M | 1.15 M | 704 K | 1.84 M | 3.74 M | 2.71 M | 2.65 M | 2.2 M | -501 K | -389 K | 872 K | -639 K | -171 K |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet GeoVax Labs
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
170 K | 197 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.88 M | 2.49 M | - | - | - | - | - | - | - | - | - | - | - | - | 6.79 M | - | 5.5 M | 7.44 M | 336 K | 359 K | 464 K | 825 K | 825 K | 825 K | 825 K | 2.04 M | 2.04 M | 2.04 M | 2.04 M | 1.66 M | 1.66 M | 1.66 M | 1.66 M | 811 K | 811 K | 811 K | 811 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-161 M | -156 M | -146 M | -140 M | -135 M | -129 M | -121 M | -115 M | -110 M | -104 M | -96.8 M | -88.4 M | -82.4 M | -78.4 M | -73 M | - | -66.8 M | -64.4 M | -50.6 M | -48.7 M | -47.4 M | -45.8 M | -45.8 M | -45.8 M | -45.8 M | -42.8 M | -42.8 M | -42.8 M | -42.8 M | -40.5 M | -40.5 M | -40.5 M | -40.5 M | -37.9 M | -37.9 M | -37.9 M | -37.9 M | -35.7 M | -35.7 M | -35.7 M | -35.7 M | -32.5 M | -32.5 M | -32.5 M | -32.5 M | -29.8 M | -29.8 M | -29.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
4.64 M | 2.98 M | 6.73 M | 5.35 M | 10.8 M | 8.16 M | 11.1 M | 4.1 M | 3.36 M | 9.28 M | 16.2 M | 21.2 M | 27.4 M | 31.3 M | 38.6 M | - | 16.9 M | 11.8 M | 18.3 M | 19.8 M | 21.1 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 469 K | 469 K | 469 K | 469 K | 642 K | 642 K | 642 K | 642 K | 490 K | 490 K | 490 K | 490 K | 610 K | 610 K | 610 K | 610 K | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 2.84 M | 2.84 M | 2.84 M | 2.84 M | 1.48 M | 1.48 M | 1.48 M | 1.48 M | 1.65 M | 1.65 M | 1.65 M | 1.65 M |
Cash and Cash Equivalents |
3.14 M | 1.27 M | 5.01 M | 3.09 M | 7.44 M | 5.51 M | 8.59 M | 1.56 M | 769 K | 6.45 M | 12.7 M | 17.8 M | 23.8 M | 27.6 M | 34.7 M | - | 16.3 M | 11.4 M | 18.1 M | 19.5 M | 20.8 M | 9.88 M | 9.88 M | 9.88 M | 9.88 M | 283 K | 283 K | 283 K | 283 K | 260 K | 260 K | 260 K | 260 K | 313 K | 313 K | 313 K | 313 K | 454 K | 454 K | 454 K | 454 K | 1.06 M | 1.06 M | 1.06 M | 1.06 M | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 2.51 M | 2.51 M | 2.51 M | 2.51 M | 1.04 M | 1.04 M | 1.04 M | 1.04 M | 1.17 M | 1.17 M | 1.17 M | 1.17 M |
Book Value |
1.76 M | 494 K | - | - | - | - | - | - | - | - | - | - | - | 31.3 M | 31.8 M | - | 11.4 M | 4.36 M | 18 M | 19.5 M | 20.7 M | 9.57 M | 9.57 M | 9.57 M | 9.57 M | -1.57 M | -1.57 M | -1.57 M | -1.57 M | -1.02 M | -1.02 M | -1.02 M | -1.02 M | -321 K | -321 K | -321 K | -321 K | 610 K | 610 K | 610 K | 610 K | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 2.84 M | 2.84 M | 2.84 M | 2.84 M | 1.48 M | 1.48 M | 1.48 M | 1.48 M | 1.65 M | 1.65 M | 1.65 M | 1.65 M |
Total Shareholders Equity |
1.76 M | 494 K | 4.91 M | 2.82 M | 7.9 M | 5.05 M | 8.5 M | -2.31 M | 54.3 K | 5.76 M | 9.12 M | 17.2 M | 22.9 M | 26.6 M | 31.8 M | 27.9 M | 11.4 M | 4.36 M | 18 M | 19.5 M | 20.7 M | 9.57 M | 9.57 M | 9.57 M | 9.57 M | -1.57 M | -1.57 M | -1.57 M | -1.57 M | -1.02 M | -1.02 M | -1.02 M | -1.02 M | -321 K | -321 K | -321 K | -321 K | 240 K | 240 K | 240 K | 240 K | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.15 M | 1.15 M | 1.15 M | 1.15 M | 2.53 M | 2.53 M | 2.53 M | 2.53 M | 1.15 M | 1.15 M | 1.15 M | 1.15 M | 704 K | 704 K | 704 K | 704 K |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of GeoVax Labs, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.